Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · Real-Time Price · USD
1.990
-0.040 (-1.97%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Aadi Bioscience Market Cap
Aadi Bioscience has a market cap or net worth of $48.98 million as of October 29, 2024. Its market cap has decreased by -52.76% in one year.
Market Cap
48.98M
Enterprise Value
-28.53M
1-Year Change
-52.76%
Ranking
Category
Stock Price
$1.99
Market Cap Chart
Since August 9, 2017, Aadi Bioscience's market cap has decreased from $162.50M to $48.98M, a decrease of -69.86%. That is a compound annual growth rate of -15.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 50.00M | 1.01% |
| Dec 29, 2023 | 49.50M | -84.19% |
| Dec 30, 2022 | 313.00M | -37.97% |
| Dec 31, 2021 | 504.60M | 992.21% |
| Dec 31, 2020 | 46.20M | 82.61% |
| Dec 31, 2019 | 25.30M | -63.33% |
| Dec 31, 2018 | 69.00M | -46.35% |
| Dec 29, 2017 | 128.60M | -20.86% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lucid Diagnostics | 52.37M |
| OncoCyte | 52.19M |
| Envoy Medical | 50.91M |
| iCAD, Inc. | 50.86M |
| Atara Biotherapeutics | 50.10M |
| Vor Biopharma | 49.59M |
| Protara Therapeutics | 49.51M |
| Vicarious Surgical | 49.30M |